Anna Truini

2.7k total citations
31 papers, 731 citations indexed

About

Anna Truini is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Anna Truini has authored 31 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Anna Truini's work include Lung Cancer Treatments and Mutations (16 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (6 papers). Anna Truini is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (6 papers). Anna Truini collaborates with scholars based in Italy, United States and United Kingdom. Anna Truini's co-authors include Angela Alama, Carlo Genova, Francesco Grossi, Simona Coco, Erika Rijavec, Maria Giovanna Dal Bello, Giulia Barletta, Federica Biello, Irene Vanni and Francesco Boccardo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Anna Truini

29 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Truini Italy 18 356 337 336 300 55 31 731
Dorota Kwapisz Poland 6 205 0.6× 302 0.9× 256 0.8× 346 1.2× 51 0.9× 9 608
Pablo Reclusa Belgium 10 557 1.6× 200 0.6× 470 1.4× 173 0.6× 49 0.9× 15 762
Shude Cui China 14 233 0.7× 139 0.4× 276 0.8× 290 1.0× 55 1.0× 42 610
Xingxiang Pu China 17 570 1.6× 253 0.8× 514 1.5× 365 1.2× 76 1.4× 76 1.0k
Christina Demuth Denmark 15 244 0.7× 249 0.7× 305 0.9× 363 1.2× 135 2.5× 30 677
Martha Zavridou Greece 12 335 0.9× 127 0.4× 430 1.3× 282 0.9× 40 0.7× 18 659
Cristin Roma Italy 17 260 0.7× 212 0.6× 265 0.8× 349 1.2× 137 2.5× 32 629
Marianne Oulhen France 13 205 0.6× 365 1.1× 501 1.5× 560 1.9× 46 0.8× 20 756
Buhai Wang China 13 239 0.7× 245 0.7× 185 0.6× 269 0.9× 20 0.4× 41 630
Anwen Xiong China 13 225 0.6× 231 0.7× 154 0.5× 289 1.0× 22 0.4× 38 559

Countries citing papers authored by Anna Truini

Since Specialization
Citations

This map shows the geographic impact of Anna Truini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Truini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Truini more than expected).

Fields of papers citing papers by Anna Truini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Truini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Truini. The network helps show where Anna Truini may publish in the future.

Co-authorship network of co-authors of Anna Truini

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Truini. A scholar is included among the top collaborators of Anna Truini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Truini. Anna Truini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Truini, Anna, Jacqueline H. Starrett, Tyler F. Stewart, et al.. (2019). The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma. Clinical Cancer Research. 25(21). 6382–6391. 38 indexed citations
2.
Coco, Simona, Silvia Bonfiglio, Davide Cittaro, et al.. (2019). Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer. Cancers. 11(4). 441–441. 3 indexed citations
3.
Truini, Anna, Giovanni Germano, & Alberto Bardelli. (2018). Inactivation of DNA repair—prospects for boosting cancer immune surveillance. Genome Medicine. 10(1). 91–91. 7 indexed citations
4.
Coco, Simona, Angela Alama, Irene Vanni, et al.. (2017). Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy. International Journal of Molecular Sciences. 18(5). 1035–1035. 37 indexed citations
5.
Biello, Federica, Giovanni Burrafato, Erika Rijavec, et al.. (2016). Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry. 16(9). 1142–1154. 8 indexed citations
6.
Bonfiglio, Silvia, Irene Vanni, Valeria Rossella, et al.. (2016). Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples. BMC Cancer. 16(1). 692–692. 21 indexed citations
7.
Vanni, Irene, Simona Coco, Silvia Bonfiglio, et al.. (2016). Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma. Medicine. 95(48). e5447–e5447. 11 indexed citations
8.
Truini, Anna, Simona Coco, Carlo Genova, et al.. (2016). Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma. MicroRNA. 5(1). 12–18. 9 indexed citations
9.
Truini, Anna, Alberto Cavazza, Paolo Spagnolo, et al.. (2015). Classification of different patterns of pulmonary adenocarcinomas. Expert Review of Respiratory Medicine. 9(5). 571–586. 17 indexed citations
10.
Vanni, Irene, Simona Coco, Anna Truini, et al.. (2015). Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform. International Journal of Molecular Sciences. 16(12). 28765–28782. 33 indexed citations
11.
Nadal, Ernest, Anna Truini, Asuka Nakata, et al.. (2015). A Novel Serum 4-microRNA Signature for Lung Cancer Detection. Scientific Reports. 5(1). 12464–12464. 108 indexed citations
12.
Alama, Angela, Anna Truini, Simona Coco, Carlo Genova, & Francesco Grossi. (2014). Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer. Drug Discovery Today. 19(10). 1671–1676. 33 indexed citations
13.
Genova, Carlo, Erika Rijavec, Giulia Barletta, et al.. (2014). Afatinib for the treatment of advanced non-small-cell lung cancer. Expert Opinion on Pharmacotherapy. 15(6). 889–903. 20 indexed citations
14.
Coco, Simona, Anna Truini, Angela Alama, et al.. (2014). Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition. Targeted Oncology. 10(3). 393–404. 35 indexed citations
15.
Coco, Simona, Anna Truini, Irene Vanni, et al.. (2014). Next Generation Sequencing in Non-Small Cell Lung Cancer: New Avenues Toward the Personalized Medicine. Current Drug Targets. 16(1). 47–59. 38 indexed citations
16.
Truini, Anna, Angela Alama, Maria Giovanna Dal Bello, et al.. (2014). Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System. Frontiers in Oncology. 4. 242–242. 58 indexed citations
17.
Rijavec, Erika, Carlo Genova, Giulia Barletta, et al.. (2014). Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy. Expert Opinion on Biological Therapy. 14(7). 1007–1017. 10 indexed citations
18.
Nadal, Ernest, Guoan Chen, Lin Lin, et al.. (2013). Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma. Clinical Cancer Research. 19(24). 6842–6852. 53 indexed citations
19.
Genova, Carlo, Erika Rijavec, Anna Truini, et al.. (2013). Pemetrexed for the treatment of non-small cell lung cancer. Expert Opinion on Pharmacotherapy. 14(11). 1545–1558. 24 indexed citations
20.
Dono, Mariella, Carlotta Massucco, Silvana Chiara, et al.. (2012). Low Percentage of KRAS Mutations Revealed by Locked Nucleic Acid Polymerase Chain Reaction: Implications for Treatment of Metastatic Colorectal Cancer. Molecular Medicine. 18(12). 1519–1526. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dorota Kwapisz Breakdown of academic impact, for papers by Pablo Reclusa Breakdown of academic impact, for papers by Shude Cui Breakdown of academic impact, for papers by Xingxiang Pu Breakdown of academic impact, for papers by Christina Demuth Breakdown of academic impact, for papers by Martha Zavridou Breakdown of academic impact, for papers by Cristin Roma Breakdown of academic impact, for papers by Marianne Oulhen Breakdown of academic impact, for papers by Buhai Wang Breakdown of academic impact, for papers by Anwen Xiong
Rankless by CCL
2026